Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04505579 · ClinicalTrials.gov registry record

The Tether™ - Vertebral Body Tethering System Post Approval Study

A clinical trial of Scoliosis Idiopathic, sponsored by ZimVie.

Recruiting
Registry status
200
Enrollment target
10
Study locations

NCT04505579: Recruiting study of Scoliosis Idiopathic, sponsored by ZimVie.

NCT04505579 is a study of Scoliosis Idiopathic that is actively recruiting participants, run by ZimVie. The registered enrollment target is 200 participants, below the 264-participant average among 5 other Scoliosis Idiopathic trials with a reported enrollment target (24% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04505579, a study of Scoliosis Idiopathic, is actively recruiting participants, sponsored by ZimVie.

RECRUITING
Registry status
200 participants
Enrollment target
10
Study locations

Study Summary

This study is an opportunity to provide continued reasonable assurance of the safety and probable benefit of The Tether HUD. The study will collect long term safety and efficacy information from patients who have had their idiopathic scoliosis treated via anterior vertebral body tethering (AVBT) with The Tether.

Primary Outcome

The primary safety endpoint is the rate of Serious Adverse Events (SAEs) and device- and/or procedure-related Adverse Events (AEs)

Conditions Studied

Interventions

  • DEVICE Anterior Vertebral Body Tethering

Study Locations (10)

California

  • Rady Children's Hospital - San Diego

Colorado

  • Children's Hospital Colorado - Aurora

Florida

  • Nemours Children's Health - Jacksonville

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Louisiana

  • Ochsner Health - New Orleans

Minnesota

  • Mayo Clinic - Rochester

Missouri

  • University of Missouri - Columbia - Columbia

New York

  • Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-10-29
Est. Completion 2027-12-31
ZimVie

10 total trials

What NCT04505579 shows while recruiting

NCT04505579 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 264-participant average among 5 other Scoliosis Idiopathic trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Scoliosis Idiopathic appearing as the primary indexed condition, and to 1 intervention - of which Anterior Vertebral Body Tethering is the first listed.

NCT04505579 lists 10 locations in 10 states (California, Colorado, Florida).

Frequently Asked Questions

What is clinical trial NCT04505579 about?

NCT04505579 is a clinical study titled "The Tether™ - Vertebral Body Tethering System Post Approval Study". This study is an opportunity to provide continued reasonable assurance of the safety and probable benefit of The Tether HUD. The study will collect long term safety and efficacy information from patients who have had their idiopathic scoliosis treated via anterior vertebral body tethering (AVBT) wit...

What is the current status of trial NCT04505579?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2020-10-29. Estimated completion is 2027-12-31.

What conditions does trial NCT04505579 study?

This clinical trial studies the following conditions: Scoliosis Idiopathic.

What interventions are being tested in trial NCT04505579?

The interventions under investigation include: Anterior Vertebral Body Tethering (DEVICE).

Who is sponsoring clinical trial NCT04505579?

This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04505579 being conducted?

This trial has 10 study locations across California, Colorado, Florida, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Scoliosis Idiopathic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04505579, the US trial registry maintained by the National Library of Medicine. NCT04505579 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.